Account (3S,6S,9S,15S,18S,21S)-9-((1H-indol-3-yl)methyl)-21-amino-3-(((S)-1-amino-1-oxo-3-phenylpropan-2-yl)carbamoyl)-18-(4-hydroxybenzyl)-6,15-bis(2-(methylthio)ethyl)-5,8,11,14,17,20-hexaoxo-4,7,10,13,16,19-hexaazatricosanedioic acid
- Catalog No. :
- ACHIOX635
- CAS No. :
- 25679-24-7
- Molecular Formula :
- C49H62N10O13S2
- Molecular Weight :
- 1063.23
IUPAC Name:(3S,6S,9S,15S,18S,21S)-9-((1H-indol-3-yl)methyl)-21-amino-3-(((S)-1-amino-1-oxo-3-phenylpropan-2-yl)carbamoyl)-18-(4-hydroxybenzyl)-6,15-bis(2-(methylthio)ethyl)-5,8,11,14,17,20-hexaoxo-4,7,10,13,16,19-hexaazatricosanedioic acid
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.
Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.
0 Reviews:View Reviews
Product Information
| Product Name | (3S,6S,9S,15S,18S,21S)-9-((1H-indol-3-yl)methyl)-21-amino-3-(((S)-1-amino-1-oxo-3-phenylpropan-2-yl)carbamoyl)-18-(4-hydroxybenzyl)-6,15-bis(2-(methylthio)ethyl)-5,8,11,14,17,20-hexaoxo-4,7,10,13,16,19-hexaazatricosanedioic acid |
|---|---|
| IUPAC Name | (3S,6S,9S,15S,18S,21S)-9-((1H-indol-3-yl)methyl)-21-amino-3-(((S)-1-amino-1-oxo-3-phenylpropan-2-yl)carbamoyl)-18-(4-hydroxybenzyl)-6,15-bis(2-(methylthio)ethyl)-5,8,11,14,17,20-hexaoxo-4,7,10,13,16,19-hexaazatricosanedioic acid |
| MDL No. | MFCD00076488 |
| Molecular Formula | C49H62N10O13S2 |
| Molecular Weight | 1063.23 |
| SMILES | CSCC[C@H](NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@@H](N)CC(=O)O)C(=O)NCC(=O)N[C@@H](CC1=CNC2=CC=CC=C12)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(N)=O |
| InChI Key | OIXQINQYMGNCII-YRVFCXMDSA-N |
| Synonym | CCK-8 NON SULFATED;CCK OCTAPEPTIDE, NON-SULFATED;CCK OCTAPEPTIDE (CCK-8), NON-SULFATED;CCK-OCTAPEPTIDE (26-33) AMMONIUM;CCK, OCTAPEPTIDE (26-33), NON-SULFATED FORM;DYMGWMDF-NH2;DESULFATED CCK-8 (26-33);CK-8 UNSULFATED CHOLECYSTOKININ FRAGM |
| CAS No. | 25679-24-7 |
Synthetic Route by SureRoute
2. ACHIOX635 Molecular Building Block Synthetic Route
(5S,11S,14S,17S)-11-((1H-Indol-3-yl)methyl)-17-(((S)-1-amino-1-oxo-3-phenylpropan-2-yl)carbamoyl)-5-((S)-2-amino-3-(4-hydroxyphenyl)propanamido)-14-(2-(methylthio)ethyl)-6,9,12,15-tetraoxo-2-thia-7,10,13,16-tetraazanonadecan-19-oic acid
CCK (26-31) (non-sulfated)
(3S,6S,9S,15S,18S,21S)-9-((1H-indol-3-yl)methyl)-21-amino-3-(((S)-1-amino-1-oxo-3-phenylpropan-2-yl)carbamoyl)-18-(4-hydroxybenzyl)-6,15-bis(2-(methylthio)ethyl)-5,8,11,14,17,20-hexaoxo-4,7,10,13,16,19-hexaazatricosanedioic acid--2,2,2-trifluoroacetic acid (1/1)